Assessment identifies serum ATGL as a potential biomarker for diabetic kidney disease, suggesting its role in lipid metabolism.
Key Points
Lower serum ATGL levels were significantly correlated with impaired renal function in patients with type 2 diabetes.
The study noted a positive correlation between serum ATGL levels and estimated glomerular filtration rates (eGFR), underlining its protective role in kidney function.
Receiver operating characteristic analysis indicated that incorporating ATGL levels improved the sensitivity of traditional kidney disease markers.
Logistic regression analyses confirmed that serum ATGL is a protective factor against diabetic kidney disease development, adjusting for potential confounders.